Association of YKL-40 with endothelial dysfunction in patients with essential hypertension

Human cartilage glycoprotein 39 (YKL-40) is related with presence and extent of atherosclerosis, which can be a new biomarker of inflammation and endothelial dysfunction. The relationship between YKL-40 and endothelial dysfunction in patients with essential hypertension (EH) has not been intensively...

Full description

Saved in:
Bibliographic Details
Published in:European journal of inflammation 2020-09, Vol.18, p.205873922095993
Main Authors: Ji, Qing-hong, Zhao, Meng-meng, Gong, Hui-ping, Lv, Xian-zhong, Ma, Wei-hong
Format: Article
Language:English
Subjects:
Hypertension
Nitric oxide
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites cdi_FETCH-LOGICAL-c370t-2472ce27f205e2b44903bb852b7568ec59f449819771996aa5bae69ed640b3e63
container_end_page
container_issue
container_start_page 205873922095993
container_title European journal of inflammation
container_volume 18
creator Ji, Qing-hong
Zhao, Meng-meng
Gong, Hui-ping
Lv, Xian-zhong
Ma, Wei-hong
description Human cartilage glycoprotein 39 (YKL-40) is related with presence and extent of atherosclerosis, which can be a new biomarker of inflammation and endothelial dysfunction. The relationship between YKL-40 and endothelial dysfunction in patients with essential hypertension (EH) has not been intensively investigated. The relationship between serum level of YKL-40 and endothelial dysfunction was evaluated in 60 EH subjects and 50 normal control (NEH) subjects. Enzyme-linked immunosorbent assay (ELISA) was used to measure serum levels of YKL-40. Brachial artery flow-mediated vasodilation (FMD) was used to measure endothelial-dependent nitric oxide-mediated vasodilatory capacity as the function of endothelial index. This study demonstrated that YKL-40 expression was significantly increased (p 
doi_str_mv 10.1177/2058739220959939
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_396e8fef820641e3922ef8d388446380</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sage_id>10.1177_2058739220959939</sage_id><doaj_id>oai_doaj_org_article_396e8fef820641e3922ef8d388446380</doaj_id><sourcerecordid>2473707378</sourcerecordid><originalsourceid>FETCH-LOGICAL-c370t-2472ce27f205e2b44903bb852b7568ec59f449819771996aa5bae69ed640b3e63</originalsourceid><addsrcrecordid>eNp1kdtLwzAUxoMoOObefSz4XM2tuTyO4WU48EVBfQlpe7p11KYmHbL_3nQdCoKBEM7H73znIwehS4KvCZHyhuJMSaYpxTrTmukTNBmkdNBO0YRISlJJ5es5moWwxfEIKqRWE_Q-D8EVte1r1yauSt4eVynHyVfdbxJoS9dvoKltk5T7UO3a4oDVbdLFBmj7cARDiMWAbfYd-B7aELkLdFbZJsDs-E7Ry93t8-IhXT3dLxfzVVowifuUckkLoLKKiYHmnGvM8lxlNJeZUFBkuoqaIlpKorWwNsstCA2l4DhnINgULUff0tmt6Xz9Yf3eOFubg-D82ljf10UDhmkBqoJKUSw4geHHYlEypTgXTOHodTV6dd597iD0Zut2vo3xTcwZ88arIoVHqvAuBA_Vz1SCzbAQ83chsSUdW4Jdw6_pv_w3aJiI8Q</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2473707378</pqid></control><display><type>article</type><title>Association of YKL-40 with endothelial dysfunction in patients with essential hypertension</title><source>Publicly Available Content Database</source><source>Sage Journals GOLD Open Access 2024</source><creator>Ji, Qing-hong ; Zhao, Meng-meng ; Gong, Hui-ping ; Lv, Xian-zhong ; Ma, Wei-hong</creator><creatorcontrib>Ji, Qing-hong ; Zhao, Meng-meng ; Gong, Hui-ping ; Lv, Xian-zhong ; Ma, Wei-hong</creatorcontrib><description>Human cartilage glycoprotein 39 (YKL-40) is related with presence and extent of atherosclerosis, which can be a new biomarker of inflammation and endothelial dysfunction. The relationship between YKL-40 and endothelial dysfunction in patients with essential hypertension (EH) has not been intensively investigated. The relationship between serum level of YKL-40 and endothelial dysfunction was evaluated in 60 EH subjects and 50 normal control (NEH) subjects. Enzyme-linked immunosorbent assay (ELISA) was used to measure serum levels of YKL-40. Brachial artery flow-mediated vasodilation (FMD) was used to measure endothelial-dependent nitric oxide-mediated vasodilatory capacity as the function of endothelial index. This study demonstrated that YKL-40 expression was significantly increased (p &lt; 0.05) in EH subjects compared with NEH subjects. The FMD was significantly impaired in EH subjects compared with NEH subjects. YKL-40 was not only negatively correlated with FMD, but also with carotid artery intima-media thickness (IMT). Multiple liner regression analysis identified that YKL-40 was independent of FMD development. The level of YKL-40 was elevated in EH patients and inversely related with FMD and may be independent of endothelial dysfunction in EH.</description><identifier>ISSN: 1721-727X</identifier><identifier>ISSN: 2058-7392</identifier><identifier>EISSN: 2058-7392</identifier><identifier>DOI: 10.1177/2058739220959939</identifier><language>eng</language><publisher>London, England: SAGE Publications</publisher><subject>Hypertension ; Nitric oxide</subject><ispartof>European journal of inflammation, 2020-09, Vol.18, p.205873922095993</ispartof><rights>The Author(s) 2020</rights><rights>The Author(s) 2020. This work is licensed under the Creative Commons Attribution – Non-Commercial License https://creativecommons.org/licenses/by-nc/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c370t-2472ce27f205e2b44903bb852b7568ec59f449819771996aa5bae69ed640b3e63</cites><orcidid>0000-0002-0441-3035</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://journals.sagepub.com/doi/pdf/10.1177/2058739220959939$$EPDF$$P50$$Gsage$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2473707378?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>314,780,784,21966,25753,27853,27924,27925,37012,44590,44945,45333</link.rule.ids></links><search><creatorcontrib>Ji, Qing-hong</creatorcontrib><creatorcontrib>Zhao, Meng-meng</creatorcontrib><creatorcontrib>Gong, Hui-ping</creatorcontrib><creatorcontrib>Lv, Xian-zhong</creatorcontrib><creatorcontrib>Ma, Wei-hong</creatorcontrib><title>Association of YKL-40 with endothelial dysfunction in patients with essential hypertension</title><title>European journal of inflammation</title><description>Human cartilage glycoprotein 39 (YKL-40) is related with presence and extent of atherosclerosis, which can be a new biomarker of inflammation and endothelial dysfunction. The relationship between YKL-40 and endothelial dysfunction in patients with essential hypertension (EH) has not been intensively investigated. The relationship between serum level of YKL-40 and endothelial dysfunction was evaluated in 60 EH subjects and 50 normal control (NEH) subjects. Enzyme-linked immunosorbent assay (ELISA) was used to measure serum levels of YKL-40. Brachial artery flow-mediated vasodilation (FMD) was used to measure endothelial-dependent nitric oxide-mediated vasodilatory capacity as the function of endothelial index. This study demonstrated that YKL-40 expression was significantly increased (p &lt; 0.05) in EH subjects compared with NEH subjects. The FMD was significantly impaired in EH subjects compared with NEH subjects. YKL-40 was not only negatively correlated with FMD, but also with carotid artery intima-media thickness (IMT). Multiple liner regression analysis identified that YKL-40 was independent of FMD development. The level of YKL-40 was elevated in EH patients and inversely related with FMD and may be independent of endothelial dysfunction in EH.</description><subject>Hypertension</subject><subject>Nitric oxide</subject><issn>1721-727X</issn><issn>2058-7392</issn><issn>2058-7392</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>AFRWT</sourceid><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNp1kdtLwzAUxoMoOObefSz4XM2tuTyO4WU48EVBfQlpe7p11KYmHbL_3nQdCoKBEM7H73znIwehS4KvCZHyhuJMSaYpxTrTmukTNBmkdNBO0YRISlJJ5es5moWwxfEIKqRWE_Q-D8EVte1r1yauSt4eVynHyVfdbxJoS9dvoKltk5T7UO3a4oDVbdLFBmj7cARDiMWAbfYd-B7aELkLdFbZJsDs-E7Ry93t8-IhXT3dLxfzVVowifuUckkLoLKKiYHmnGvM8lxlNJeZUFBkuoqaIlpKorWwNsstCA2l4DhnINgULUff0tmt6Xz9Yf3eOFubg-D82ljf10UDhmkBqoJKUSw4geHHYlEypTgXTOHodTV6dd597iD0Zut2vo3xTcwZ88arIoVHqvAuBA_Vz1SCzbAQ83chsSUdW4Jdw6_pv_w3aJiI8Q</recordid><startdate>20200901</startdate><enddate>20200901</enddate><creator>Ji, Qing-hong</creator><creator>Zhao, Meng-meng</creator><creator>Gong, Hui-ping</creator><creator>Lv, Xian-zhong</creator><creator>Ma, Wei-hong</creator><general>SAGE Publications</general><general>SAGE PUBLICATIONS, INC</general><general>SAGE Publishing</general><scope>AFRWT</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-0441-3035</orcidid></search><sort><creationdate>20200901</creationdate><title>Association of YKL-40 with endothelial dysfunction in patients with essential hypertension</title><author>Ji, Qing-hong ; Zhao, Meng-meng ; Gong, Hui-ping ; Lv, Xian-zhong ; Ma, Wei-hong</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c370t-2472ce27f205e2b44903bb852b7568ec59f449819771996aa5bae69ed640b3e63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Hypertension</topic><topic>Nitric oxide</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ji, Qing-hong</creatorcontrib><creatorcontrib>Zhao, Meng-meng</creatorcontrib><creatorcontrib>Gong, Hui-ping</creatorcontrib><creatorcontrib>Lv, Xian-zhong</creatorcontrib><creatorcontrib>Ma, Wei-hong</creatorcontrib><collection>Sage Journals GOLD Open Access 2024</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>European journal of inflammation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ji, Qing-hong</au><au>Zhao, Meng-meng</au><au>Gong, Hui-ping</au><au>Lv, Xian-zhong</au><au>Ma, Wei-hong</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Association of YKL-40 with endothelial dysfunction in patients with essential hypertension</atitle><jtitle>European journal of inflammation</jtitle><date>2020-09-01</date><risdate>2020</risdate><volume>18</volume><spage>205873922095993</spage><pages>205873922095993-</pages><issn>1721-727X</issn><issn>2058-7392</issn><eissn>2058-7392</eissn><abstract>Human cartilage glycoprotein 39 (YKL-40) is related with presence and extent of atherosclerosis, which can be a new biomarker of inflammation and endothelial dysfunction. The relationship between YKL-40 and endothelial dysfunction in patients with essential hypertension (EH) has not been intensively investigated. The relationship between serum level of YKL-40 and endothelial dysfunction was evaluated in 60 EH subjects and 50 normal control (NEH) subjects. Enzyme-linked immunosorbent assay (ELISA) was used to measure serum levels of YKL-40. Brachial artery flow-mediated vasodilation (FMD) was used to measure endothelial-dependent nitric oxide-mediated vasodilatory capacity as the function of endothelial index. This study demonstrated that YKL-40 expression was significantly increased (p &lt; 0.05) in EH subjects compared with NEH subjects. The FMD was significantly impaired in EH subjects compared with NEH subjects. YKL-40 was not only negatively correlated with FMD, but also with carotid artery intima-media thickness (IMT). Multiple liner regression analysis identified that YKL-40 was independent of FMD development. The level of YKL-40 was elevated in EH patients and inversely related with FMD and may be independent of endothelial dysfunction in EH.</abstract><cop>London, England</cop><pub>SAGE Publications</pub><doi>10.1177/2058739220959939</doi><orcidid>https://orcid.org/0000-0002-0441-3035</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1721-727X
ispartof European journal of inflammation, 2020-09, Vol.18, p.205873922095993
issn 1721-727X
2058-7392
2058-7392
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_396e8fef820641e3922ef8d388446380
source Publicly Available Content Database; Sage Journals GOLD Open Access 2024
subjects Hypertension
Nitric oxide
title Association of YKL-40 with endothelial dysfunction in patients with essential hypertension
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T01%3A47%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Association%20of%20YKL-40%20with%20endothelial%20dysfunction%20in%20patients%20with%20essential%20hypertension&rft.jtitle=European%20journal%20of%20inflammation&rft.au=Ji,%20Qing-hong&rft.date=2020-09-01&rft.volume=18&rft.spage=205873922095993&rft.pages=205873922095993-&rft.issn=1721-727X&rft.eissn=2058-7392&rft_id=info:doi/10.1177/2058739220959939&rft_dat=%3Cproquest_doaj_%3E2473707378%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c370t-2472ce27f205e2b44903bb852b7568ec59f449819771996aa5bae69ed640b3e63%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2473707378&rft_id=info:pmid/&rft_sage_id=10.1177_2058739220959939&rfr_iscdi=true